Showing 12,381 - 12,400 results of 45,766 for search '(( 50 ((we decrease) OR (a decrease)) ) OR ( 5 ((nm decrease) OR (mean decrease)) ))', query time: 1.18s Refine Results
  1. 12381
  2. 12382
  3. 12383
  4. 12384
  5. 12385

    Inhibitory activity of pentacyano(isoniazid)ferrate(II), IQG-607, against promastigotes and amastigotes forms of <i>Leishmania braziliensis</i> by Camila F. Amorim (676792)

    Published 2017
    “…The pentacyano(isoniazid)ferrate(II) compound, named IQG-607, inhibits the enzyme 2-trans-enoyl-ACP(CoA) reductase from <i>M</i>. <i>tuberculosis</i>, a key component in the FASII system. …”
  6. 12386
  7. 12387

    Polylactic Acid/Polybutylene Adipate Terephthalate-Carbon Nanotube Nanobiocomposites with a Segregated Toughening Morphology Yielding Large Ductility for Biocompatible Materials by Utsab Ayan (18552401)

    Published 2025
    “…Selective deposition and encapsulation of nanodispersed multiwalled carbon nanotubes (MWCNT) exclusively within polybutylene adipate terephthalate (PBAT) microdomains in a phase-separated microstructure of 80/20 polylactic acid (PLA)/PBAT polymer nanocomposites (PNCs) were achieved by a three-step processing strategy. …”
  8. 12388
  9. 12389
  10. 12390
  11. 12391
  12. 12392
  13. 12393

    A R13A point mutation in C4 attenuates CLCuMuV infection. by Asigul Ismayil (5698946)

    Published 2018
    “…<i>eIF4α</i> was used as an internal control. Values represent means ± SE from three independent experiments. <b>(C)</b> The mutant CLCuMuV carrying C4<sup>R13A</sup> (CLCuMuV-C4<sup>R13A</sup>), which contains a R13A mutation in <i>C4</i>, showed the decreased viral symptom compared to wild type CLCuMuV. …”
  14. 12394
  15. 12395
  16. 12396

    Pseudo first-order rate constants for CIII formation (<i>k</i> CIII(obs)), enzyme inactivation (<i>k</i><sub>i(obs)</sub>) and heme bleaching (<i>k</i><sub>b(obs)</sub>) of native... by Verónica Sáez-Jiménez (731925)

    Published 2015
    “…CIII formation was measured as the absorbance increase at 581 nm (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0124750#pone.0124750.g008" target="_blank">Fig 8A</a>) and heme bleaching as the absorbance decrease at 419 nm (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0124750#pone.0124750.g008" target="_blank">Fig 8B</a>). …”
  17. 12397
  18. 12398

    CD44v6 is required for the growth of BTSC in CD44<sup>high</sup> GBM. by Mayumi Jijiwa (207098)

    Published 2011
    “…B: Treatment with siRNA decreased the expression of CD44v6 in both neurosphere (left panel) and serum-propagated CD44<sup>high</sup> GBM (middle panel). …”
  19. 12399
  20. 12400